Navigation Links
Beckman Coulter Announces Third Quarter 2008 Results
Date:10/28/2008

his transaction is subject to commercial rental tax

in accordance with applicable state laws and requested Cardbeck to

pay this assessment. During June 2007, Cardbeck and the Company

subsequently entered into a settlement of the assessment under which

the Company paid $2.4 million ($1.6 million in sales tax and $0.8

million in interest) which was accrued at June 30, 2007. The

Company also has taken steps to obtain a determination that its

payments to Cardbeck are not subject to the rental tax.

h) Beckman Coulter Foundation -- Using proceeds from the Miami vacant

land sale the company made a $9 million contribution to establish

and fund the Beckman Coulter Foundation (the "Foundation"), during

the quarter ended September 30, 2007. The contribution was

classified under other non-operating expenses.

i) Biosite break-up fee -- On May 17, 2007, the merger agreement to

acquire Biosite, Inc. was terminated by Biosite in accordance with

its terms. Pursuant to the terms of the agreement, Biosite paid the

Company a break up fee of $54 million. The Company recorded a gain

of $40.6 million (net of associated expenses of $13.4 million) in

other non-operating income during the second quarter 2007.

j) Agencourt Personal Genomics ("APG") -- In 2006, the company sold its

non-controlling interest in APG. The company received approximately

$50 million in cash and recognized a gain from the sale. This gain

and the company's share of APG's operating results were included in

discontinued operations. In connection with the sale an additional

$6 million was held in escrow. In July 2007, pursuant to the terms

of the sale agreement, the company received its $2.6 million

proportionate sha
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
2. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
3. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
4. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
5. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
6. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
7. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
8. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
9. Align Technology Announces Third Quarter Fiscal 2008 Results
10. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
11. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... What,s one of your worst memories? How did it ... felt during a negative personal experience, such as how ... lead to emotional distress, especially when you can,t stop ... creep up, thinking about the context of the memories, ... and effective way to alleviate the negative effects of ...
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... of Experimental Biology and Medicine a ... and Paul Kenis in the Institute of Genomic ... of Illinois Urbana-Champaign describe their recent work on ... variety of cell functions including energy metabolism, signaling, ... in regulating normal cellular behavior, redox status has ...
Breaking Medicine News(10 mins):Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2
... is the most common tumor to be diagnosed. It has a ... of Navarra. // Sadly, the incidence melanoma has been increasing steadily ... women aged between 19 and 50 years. In the U.S., the ... just 10 years. ,Two main factors regarded to play ...
... have unearthed a new virus in human prostate tumors that is ... it is too early to say what exactly the link between ... to determine the relationship if any. ,Scientists say that ... that had confirmed the SARS virus some three years ago. "This ...
... Coli bacteria, an infectious agent that causes food borne illness. ... accurately.// ,The unique technology developed by the University ... bacteria as part of the sensing system that includes a ... ,"Traditional methods of detection of bacteria can take ...
... the U.S. military prison in Guantanamo Bay to force ... of feeding tubes // through their noses has raised ... such practices violate the fundamental principles of medical ethics. ... to harsh interrogations, targeted at extension of co-operation by ...
... a tumor marker, elevated level of which is strongly ... used by doctors to spot early signs of prostate cancer, ... a different criterion may be needed for establishment of prostate ... of age. ,The researchers from Duke University Medical ...
... by researchers from the University of Wisconsin-Madison and University ... role in smoking. // The research mainly focused on ... regulation of emotions and studied whether they are related ... of this study were published in the journal Nicotine ...
Cached Medicine News:Health News:New Technique Could Revolutionize Melanoma Diagnosis and Treatment 2Health News:Medical Ethics Violated By Prison Officials In Guantanamo Bay 2Health News:Genetic Influence on Smoking 2
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... MORRISVILLE, N.C., Sept. 11 Clinical Logistics is pleased to announce ... Corporation (Gentris), a GLP compliant laboratory, located in Morrisville, North Carolina. ... DNA, RNA, whole blood, FFPE tissue blocks, urine, plasma, serum, saliva, ... storage conditions is available: , , ...
... YORK, Sept. 11 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova ... method for destroying breast cancer cells, using stem cell ... that enables us to identify the protein expression in ... tumors. This ability to identify the molecular markers of ...
Cached Medicine Technology:Clinical Logistics Enters Partnership with Gentris Corporation 2New stem cell identification technology could cure breast cancer 2
... Nephew ECTRA II systems permit the surgeon ... ligament endoscopically, allowing access via two portals ... endoscopic lens fogging with good air flow. ... and control. ECTRA knives permit the surgeon ...
... Screw System provides a unique option for the ... particularly the opening wedge osteotomy of the first ... Fragment Plate and Screw Set is a complete ... houses the plates, screws, and drills. It provides ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Medicine Products: